Keros Therapeutics (NASDAQ:KROS) Lifted to Hold at Zacks Investment Research
Published on: Friday 11 February 2022
Zacks Investment Research upgraded shares of Keros ... acquiring an additional 156,377 shares during the period. Candriam Luxembourg S.C.A. raised its holdings in Keros Therapeutics by 137.6% ...
News source: https://etfdailynews.com/news/keros-therapeutics-nasdaqkros-lifted-to-hold-at-zacks-investment-research/
